S
Subbarao Myla
Researcher at Memorial Hospital of South Bend
Publications - 7
Citations - 1141
Subbarao Myla is an academic researcher from Memorial Hospital of South Bend. The author has contributed to research in topics: Stroke & Carotid stenting. The author has an hindex of 7, co-authored 7 publications receiving 1110 citations.
Papers
More filters
Journal ArticleDOI
Global experience in cervical carotid artery stent placement
Michael H. Wholey,Mark H. Wholey,Klaus Mathias,Gary S. Roubin,Edward B. Diethrich,Michel Henry,Steven R. Bailey,Patrice Bergeron,Gerald Dorros,Eles G,P Gaines,Camilo R. Gomez,Bruce H. Gray,J Guimaraens,Randall T. Higashida,D S Ho,Barry T. Katzen,A Kambara,Vijay Kumar,Jean Claude Laborde,Martin B. Leon,Lim Mc,Hugo F. Londero,Juan E. Mesa,A Musacchio,Subbarao Myla,S. R. Ramee,A Rodriquez,Kenneth Rosenfield,N Sakai,Fayaz A. Shawl,Horst Sievert,George P. Teitelbaum,Jacques Theron,P Vaclav,Vozzi C,Jay S. Yadav,S I Yoshimura +37 more
TL;DR: The periprocedure risks for major and minor strokes and death are generally acceptable at this early stage of development and have not changed significantly since the first survey results.
Journal ArticleDOI
Safety and effectiveness of the INVATEC MO.MA proximal cerebral protection device during carotid artery stenting: results from the ARMOUR pivotal trial.
Gary M. Ansel,L. Nelson Hopkins,Michael R. Jaff,Paolo Rubino,J. Michael Bacharach,Dierk Scheinert,Subbarao Myla,Tony Das,Alberto Cremonesi +8 more
TL;DR: The ARMOUR trial demonstrated that the MO.MA® Proximal Cerebral Protection Device is safe and effective for high surgical risk patients undergoing CAS, and the absence of stroke in symptomatic patients is the lowest rate reported in any independently adjudicated prospective multicenter registry trial to date.
Journal ArticleDOI
Protected carotid stenting in high-risk patients with severe carotid artery stenosis.
Robert D. Safian,John F. Bresnahan,Michael R. Jaff,Malcolm Foster,J. Michael Bacharach,Brijeshwar Maini,Mark Turco,Subbarao Myla,Gustav Eles,Gary M. Ansel,Create Pivotal Trial Investigators +10 more
TL;DR: For some patients with severecarotid stenosis and high-risk features for carotid endarterectomy,Carotid artery stenting with distal embolic protection is a reasonable alternative for revascularization.
Journal ArticleDOI
Safety, efficacy, and durability of carotid artery stenting for restenosis following carotid endarterectomy: a multicenter study.
Gishel New,Gary S. Roubin,Gary S. Roubin,Sriram S. Iyer,Sriram S. Iyer,Jiri J. Vitek,Jiri J. Vitek,Mark H. Wholey,Edward B. Diethrich,L. Nelson Hopkins,Robert W. Hobson,Martin B. Leon,Subbarao Myla,Fayaz A. Shawl,Stephen R. Ramee,Jay S. Yadav,Kenneth Rosenfield,Ming W. Liu,Camilo R. Gomez,Nadim Al-Mubarak,William A. Gray,Walter A. Tan,Jonathan Goldstein,Richard S. Stack +23 more
TL;DR: Results of late follow-up suggest that this technique is durable and efficacious, and can be performed in patients with restenosis following carotid endarterectomy with 30-day complication rates comparable to those of most published studies on repeat carotin stent procedures.
Journal ArticleDOI
Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ: 1-year results in the CABERNET trial.
L. Nelson Hopkins,Subbarao Myla,Eberhard Grube,J. Christopher Wehman,Elad I. Levy,Robert M. Bersin,James Joye,Dominic J. Allocco,Lynne Kelley,Donald S. Baim +9 more
TL;DR: The multicenter, single‐arm CABERNET trial evaluated outcomes in high‐surgical‐risk patients with carotid artery stenosis treated with the NexStent® plus FilterWire EX®/EZ™ Emboli Protection System.